Magnesium Citrate Saline Laxative Recalled for Manufacturing Deviations
Vi-Jon, LLC voluntarily recalled Magnesium Citrate Saline Laxative due to manufacturing process deviations. Over 8 million units of the product were distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II voluntary recall with CGMP manufacturing deviations. No illnesses, injuries, or hospitalizations are reported. This is a precautionary manufacturing compliance issue.
Plain-English summary
Vi-Jon, LLC issued a voluntary recall of Magnesium Citrate Saline Laxative oral solution (10 FL OZ / 296 mL bottles, 1.745 g per bottle) in grape flavor. The recall affects a total of 8,064,834 units distributed nationwide in the United States, as well as in Canada and Panama.
The recall was initiated due to CGMP (Current Good Manufacturing Practice) deviations identified by the manufacturer. CGMP deviations represent departures from federal manufacturing standards required for pharmaceutical production and may affect product quality and safety.
The affected product was distributed under multiple store brands, including Best Choice, CVS Health, Equate, H-E-B, Kroger, Leader, Rexall, and Walgreens. All lots remaining within their expiration date were included in the recall. The firm voluntarily initiated the recall, and it was terminated in May 2024 following resolution of the manufacturing issues.
The recalled product
- Product
- Magnesium Citrate SALINE LAXATIVE, Oral Solution, 1.745 g, Grape Flavor, 10 FL OZ (296 mL), a) Best Choice UPC 0 70038 66220 4 Proudly Distributed By: Valu Merchandisers, Co. 5000 Kansas Ave Kansas City, KS 66106; b) CVS Health UPC 0 50428 30745 8 Distributed by: CVS Pharmacy,
- Manufacturer
- Vi-Jon, LLC
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27